21 unknown, 12 completed, 2 active not recruiting, 2 recruiting. 29 Phase 2, 9 Phase 1, 2 Phase 3, 1 Not applicable.
Follow Herbert Irving Comprehensive Cancer Center: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer E-EDV-D682, EDV-GC, Gemcitabine - Pancreatic Cancer, Metastatic, PDAC - Pancreatic Ductal Adenocarcinoma | Phase 1 / Phase 2 | Recruiting | Engeneic Pty Limited | 144 | 2026-01-12 | 2026-02-27 |
| Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer. Tamoxifen 10 MG, Exemestane 25 MG - Breast Cancer | Phase 2 | Recruiting | Andrea DeCensi | 140 | 2025-10-01 | 2025-11-18 |
| Testing Gene PilotLX With Latinx Cancer Patients Gene PilotLX - Cancer | Not applicable | Active not recruiting | Fox Chase Cancer Center | 239 | 2025-05-30 | 2026-09-02 |
| Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast Anastrozole, Palbociclib, Trastuzumab - Breast Neoplasms, Breast Diseases | Phase 1 / Phase 2 | Active not recruiting | Icahn School of Medicine at Mount Sinai | 44 | 2017-12-20 | 2026-07-29 |
| Doxorubicin Hydrochloride Liposome, Melphalan, and Bortezomib in Treating Patients With Relapsed or Refractory Stage I, Stage II, or Stage III Multiple Myeloma bortezomib, melphalan, pegylated liposomal doxorubicin hydrochloride - Multiple Myeloma and Plasma Cell Neoplasm | Phase 1 / Phase 2 | Unknown | Herbert Irving Comprehensive Cancer Center | 32 | 2006-02-01 | 2014-01-10 |
| Collecting Stem Cells in Patients With Waldenstrom's Macroglobulinemia leukapheresis - Lymphoma | Unknown | Herbert Irving Comprehensive Cancer Center | 40 | 2005-11-01 | 2013-12-18 | |
| G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission filgrastim - Leukemia | Phase 1 | Completed | Herbert Irving Comprehensive Cancer Center | 20 | 2005-01-01 | 2013-02-04 |
| Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma temozolomide, thalidomide - Sarcoma | Phase 2 | Unknown | Herbert Irving Comprehensive Cancer Center | 2002-03-01 | 2014-01-06 | |
| Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer ALVAC-CEA-B7.1 vaccine, tetanus toxoid, FOLFIRI regimen - Colorectal Cancer | Phase 2 | Unknown | Herbert Irving Comprehensive Cancer Center | 2001-12-01 | 2014-01-06 | |
| Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer zoledronic acid - Breast Cancer, Osteoporosis | Phase 3 | Completed | Herbert Irving Comprehensive Cancer Center | 120 | 2001-12-01 | 2014-01-06 |
| Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy silymarin - Drug/Agent Toxicity by Tissue/Organ, Leukemia | Phase 2 | Completed | Herbert Irving Comprehensive Cancer Center | 50 | 2001-11-01 | 2013-12-18 |
| Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma recombinant interferon alfa, thalidomide, adjuvant therapy - Sarcoma | Phase 2 | Unknown | Herbert Irving Comprehensive Cancer Center | 2001-10-01 | 2014-01-06 | |
| Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma MAGE-10.A2, MART-1 antigen, NY-ESO-1 peptide vaccine - Melanoma (Skin) | Phase 1 | Unknown | Herbert Irving Comprehensive Cancer Center | 2001-10-01 | 2013-12-18 | |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma recombinant vaccinia-TRICOM vaccine - Melanoma (Skin) | Phase 1 | Unknown | Herbert Irving Comprehensive Cancer Center | 2001-08-01 | 2013-12-18 | |
| Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer recombinant interferon gamma, cisplatin, doxorubicin hydrochloride - Malignant Mesothelioma | Phase 2 | Unknown | Herbert Irving Comprehensive Cancer Center | 2001-05-01 | 2014-01-06 | |
| CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma CP4071 - Sarcoma | Phase 2 | Unknown | Herbert Irving Comprehensive Cancer Center | 2000-10-01 | 2014-01-06 | |
| Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma temozolomide - Brain and Central Nervous System Tumors | Phase 2 | Unknown | Herbert Irving Comprehensive Cancer Center | 2000-02-01 | 2014-01-06 | |
| Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer filgrastim, CMF regimen, carboplatin - Breast Cancer | Phase 2 | Unknown | Herbert Irving Comprehensive Cancer Center | 2000-01-01 | 2014-01-06 | |
| Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis Melphalan, Autologous Stem Cell Transplantation - Amyloidosis | Phase 2 | Completed | Herbert Irving Comprehensive Cancer Center | 25 | 1999-07-01 | 2008-06-09 |
| Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis filgrastim, recombinant interferon alfa, sargramostim - Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Completed | Herbert Irving Comprehensive Cancer Center | 75 | 1999-07-01 | 2013-02-04 |
Showing 20 of 37. Sign in to see all of them.
Breast Neoplasms (6) · Leukemia (5) · Neoplasms, Plasma Cell (5) · Sarcoma (5) · Lymphoma (4) · Multiple Myeloma (4) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (4) · Astrocytoma (3) · Brain Neoplasms (3) · Central Nervous System Neoplasms (3) · Leukemia, Myeloid, Acute (3) · Leukemia, Myeloid, Chronic-Phase (3) · Oligodendroglioma (3) · Ovarian Neoplasms (3) · Prostatic Neoplasms (3)
Filgrastim (9) · Peripheral Blood Stem Cell Transplantation (9) · Carboplatin (6) · Cyclophosphamide (6) · Docetaxel (5) · Melphalan (5) · Thiotepa (5) · Etoposide (4) · Cisplatin (3) · Estramustine (3) · Gemcitabine (3) · Paclitaxel (3) · Radiotherapy (3) · Temozolomide (3) · sargramostim (3)
United States (35) · Canada (2) · Italy (1)
Robert N. Taub, MD, PhD (6) · Charles S. Hesdorffer, MD (5) · Amy D. Tiersten, MD (4) · David G. Savage, MD (3) · Daniel P. Petrylak, MD (2) · Gwen L. Nichols, MD (2) · Howard L. Kaufman, MD (2) · Ajai Chari, MD (1) · Amy Tiersten, MD (1) · Andrea U De Censi, MD (1) · Casilda Balmaceda, MD (1) · Charles S. Hesdorffer (1) · Dawn Hershman, MD (1) · Dr Himanshu Brahmbhatt, Ph.D (1) · Dr Jennifer MacDiarmid, Ph.D (1)
PMID 14766258, PMID 15107815, PMID 17194907, PMID 17563739, PMID 18676757, PMID 18711172, PMID 19043564, PMID 20014183, PMID 20022990, PMID 38979716
U54CA221705 (1)